HomeNewsBusinessWe expect international tourism to revive in the second half of FY23 and add to our profitability: Thomas Cook MD Madhavan Menon
Trending Topics

We expect international tourism to revive in the second half of FY23 and add to our profitability: Thomas Cook MD Madhavan Menon

The domestic tourism market will return to pre-pandemic levels by the July-September period, says Menon.

June 13, 2022 / 16:41 IST
Story continues below Advertisement

Thomas Cook Managing Director Madhavan Menon says that his company will not give up on cost cuts it had undertaken during the pandemic. He added that while the company has started hiring people again, the adoption of better technology limits the number of employees it will need compared to the pre-pandemic years.

Menon added that he expects the domestic tourism market to return to pre-pandemic levels by the end of June and expects the international tourism sector to recover to pre-pandemic levels by the end of 2022. He expects corporate travel to drive profitability for Thomas Cook in the first half of 2022-23, and international tourism to revive significantly post-October 2022.

Story continues below Advertisement

The Thomas Cook MD also said that Indian tourists will look to travel to exotic locations in Southeast Asia this year and once visa renewal issues in Europe are fixed people will look to travel to Europe in the second half of 2022-23.

Edited Excerpts:

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show